CGON
CG Oncology, Inc.
70.89
2 x 50.79
2 x 89.47
bid
ask
-
0.16
0.23%
2 @ 08:51 AM
70.94 +0.05 (0.07%)
| Ytd | 70.74% | |
| 1y | 169.03% |
69.75
day range
71.50
23.65
52 week range
77.00
| Open | 70.33 | Prev Close | 71.05 | Low | 69.75 | High | 71.50 | Mkt Cap | 6.25B |
| Vol | 1.00M | Avg Vol | 1.10M | EPS | -2.34 | P/E | N/A | Forward P/E | -25.51 |
| Beta | 0.31 | Short Ratio | 11.03 | Inst. Own | 109.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 64.68 | 200-d Avg | 53.38 | 1yr Est | 90.29 |
| Income Statement | |||
| Total Revenue | 1.08M | ||
| Revenues (USD) | 1.08M | ||
| Cost of Revenue | 2.96M | ||
| Gross Profit | -1.88M | ||
| Operating Expenses | 64.51M | ||
| Research and Development Expense | 43.73M | ||
| Selling, General and Administrative Expense | 20.78M | ||
| Operating Income | -66.39M | ||
| Net Income | -60.20M | ||
| Net Income Common Stock | -60.20M | ||
| Net Income Common Stock (USD) | -60.20M | ||
| Consolidated Income | -60.20M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -60.20M | ||
| Earning Before Interest & Taxes (USD) | -60.20M | ||
| Weighted Average Shares | 84.52M | ||
| Weighted Average Shares Diluted | 84.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.70M | ||
| Cash and Equivalents (USD) | 33.70M | ||
| Investments | 1.04B | ||
| Investments Current | 1.04B | ||
| Trade and Non-Trade Receivables | 1.27M | ||
| Current Assets | 1.10B | ||
| Property, Plant & Equipment Net | 19.59M | ||
| Total Assets | 1.14B | ||
| Debt Current | 1.07M | ||
| Total Debt | 7.58M | ||
| Current Liabilities | 35.22M | ||
| Debt Non-Current | 6.51M | ||
| Total Liabilities | 43.48M | ||
| Accumulated Retained Earnings (Deficit) | -439.18M | ||
| Shareholders Equity | 1.09B | ||
| Shareholders Equity (USD) | 1.09B | ||
| Assets Non-Current | 33.12M | ||
| Total Debt (USD) | 7.58M | ||
| Goodwill and Intangible Assets | 10.86M | ||
| Inventory | 1.49M | ||
| Liabilities Non-Current | 8.27M | ||
| Trade and Non-Trade Payables | 8.24M | ||
| Tax Liabilities | 307.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 854.00K | ||
| Net Cash Flow from Financing | 393.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.21M | ||
| Capital Expenditure | -304.00K | ||
| Issuance (Purchase) of Equity Shares | 393.17M | ||
| Net Cash Flow from Investing | -334.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -334.54M | ||
| Net Cash Flow from Operations | -56.94M | ||
| Share Based Compensation | 6.47M | ||